Avidity Partners Management LP Adaptimmune Therapeutics PLC Transaction History

Avidity Partners Management LP

  • $885 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$4.0 - $9.2 $8.34 Million - $19.2 Million
-2,084,700 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$7.66 - $10.78 $4.95 Million - $6.97 Million
646,700 Added 44.97%
2,084,700 $16.6 Million
Q2 2020

Aug 14, 2020
BUY
$2.58 - $12.1 $3.71 Million - $17.4 Million
1,438,000 New
1,438,000 $14.4 Million

Others Institutions Holding ADAP

# of Institutions
84
Shares Held
123M
Call Options Held
34.2K
Put Options Held
16.3K
View Full List

About Adaptimmune Therapeutics PLC

ADAP Quotes by TradingView
  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $39.2M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email